Article Text

Cross-reacting antibodies in coeliac disease?
  1. K E A LUNDIN
  1. Department of Gastroenterology,
  2. Ullevaal Hospital,
  3. 0407 Oslo,
  4. Norway

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

See article on page 168

Most patients with coeliac disease have antibodies to wheat gliadin, reticulin, and endomysium. In 1997 a seminal paper showed that at least a substantial fraction of anti-endomysial antibodies (EMA) recognises the endogenous enzyme tissue transglutaminase (tTG).1 However, antibodies recognising other antigens can also be found and in this issue (see page 168) Krupičková and colleagues attempt to characterise these antibodies.

Anti-gliadin antibodies (AGA) were isolated from coeliac serum samples using (semi)purified α-gliadin as the substrate. These antibodies were tested for specificity using a synthetic α-gliadin peptide competition assay. This important study is the first of its kind. An interesting finding is that the antibody responses are directed towards a limited set of epitopes. These epitopes do not overlap with peptides recognised by small intestinal HLA-DQ restricted T cells,2 ,3 but our current knowledge is too …

View Full Text

Linked Articles